Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 - PRESS RELEASE DATED 1/20/11 - MERIDIAN BIOSCIENCE INC | ex991012011.htm |
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
Date of Report (Date of earliest event reported):
|
January 20, 2011
|
|
MERIDIAN BIOSCIENCE, INC.
|
|
(Exact name of registrant as specified in its charter)
|
|
Ohio
|
0-14902
|
31-0888197
|
||
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No. )
|
|
3471 River Hills Drive, Cincinnati, Ohio
|
45244
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
Registrant’s telephone number, including area code
|
(513) 271-3700
|
|
(Former name or former address, if changed since last report.)
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 2.02. Results of Operations and Financial Condition.
On January 20, 2011, the Company issued a press release announcing its financial results for the fiscal quarter ended December 31, 2010. A copy of the press release is furnished as Exhibit 99.1 to this report and is incorporated herein by reference.
Item 5.07. Submission of Matters to a Vote of Security Holders.
The Annual Meeting of Shareholders of Meridian Bioscience, Inc. was held on January 20, 2011 at which the following matters were submitted to a vote of shareholders:
(a) Votes regarding the election of six directors:
|
Name
|
For
|
Against
|
Abstain
|
Broker
Non-Votes
|
|
James M. Anderson
|
22,155,345
|
10,192,478
|
|
15,810
|
5,602,995
|
|
John A. Kraeutler
|
22,625,903
|
9,723,276
|
|
14,454
|
5,602,995
|
|
Gary P. Kreider
|
16,655,896
|
15,688,644
|
|
19,093
|
5,602,995
|
|
William J. Motto
|
22,584,618
|
9,764,161
|
|
14,854
|
5,602,995
|
|
David C. Phillips
|
21,694,721
|
10,654,793
|
|
14,119
|
5,602,995
|
|
Robert J. Ready
|
20,166,309
|
12,183,220
|
|
14,104
|
5,602,995
|
(b) Votes regarding the ratification of the Audit Committee’s appointment of Grant Thornton LLP as Meridian’s Independent Registered Public Accounting Firm for fiscal 2011.
|
For
|
Against
|
Abstain
|
|
37,677,748
|
260,066
|
28,814
|
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
|
99.1
|
Press Release dated January 20, 2011.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
MERIDIAN BIOSCIENCE, INC.
|
|||
|
Date: January 21, 2011
|
By:
|
/s/ Melissa A. Lueke | |
| Melissa A. Lueke | |||
| Executive Vice President and Chief Financial Officer | |||
| (Principal Accounting Officer) | |||